Here are five insights:
1. The Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality study involves bone marrow derived stem cells, and is registered with the National Institute of Health.
2. Researchers injected patients with thoracic or lumbar spinal cord injuries or diseases with BMSCs. The patients experienced motor, sensory and/or bowel-bladder dysfunction.
3. The study also deployed exoskeleton and virtual reality use for motor and sensory neuron stimulation.
4. At one month, the study’s initial patient experienced recovery of neurologic sensation. The press release notes, “one to two spinal cord segments improved from the original loss of function level.”
5. Steven Levy MD, CEO of MD Stem Cells, serves as the study’s director.
More articles on biologics:
FDA clarifies regenerative medicine policies with new framework — 5 things to know
Private clinics promoting unapproved stem cell treatments in Canada: 5 insights
65 spine surgeons on the forefront of biologics & stem cells
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
